CardioComm Solutions Inc.  

(Public, CVE:EKG)   Watch this stock  
Find more results for EKG
0.0000 (0.00%)
Jan 23 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.04 - 0.04
52 week 0.03 - 0.14
Open 0.04
Vol / Avg. 2,000.00/41,865.00
Mkt cap 3.83M
P/E     -
Div/yield     -
EPS -0.02
Shares 109.32M
Beta 1.92
Inst. own     -

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -221.20% -100.45%
Operating margin -230.24% -101.88%
EBITD margin - -98.07%
Return on average assets -120.90% -170.16%
Return on average equity - -1853.44%
Employees 16 -
CDP Score - -


200-259 Yorkland Rd
+1-416-9779425 (Phone)
+1-250-7441866 (Fax)

Website links


CardioComm Solutions, Inc. is engaged in developing advanced software and hardware related to a personal heart arrhythmia monitoring system. The Company�s technology is used in products for the recording viewing, analyzing and storing electrocardiograms (ECGs), for diagnosis and management of cardiac patients. Its products are marketed as Global EKG Management System (GEMS and GlobalCardio). The Company's products are sold worldwide to hospitals, call centers and physician�s offices through a combination of its external distribution network and its North American based sales team. The Company also has multiple-element sales arrangements where software licenses, the associated post-contract services (PCS) and ongoing services are sold together. In February 2012, the Company purchased ECG recorder devices from MD Primer.

Officers and directors

Anatoly Langer M.D. Chairman of the Board
Etienne Grima Chief Executive Officer, Corporate Secretary, Director
Wendy Hsieh Chief Financial Officer
Simi Grosman Director
Yury Levin Independent Director
David Newman Independent Director
William E. Smith Independent Director
Age: 62